Leaving these accounts open could tarnish your golden years.
Yahoo Finance Live anchors discuss stock performance for cruise lines.
Yahoo Finance Live examines Carnival Cruise's stock after its latest earnings miss signifies a much longer path to profitability than expected.
September is living up to its reputation as an ugly month for stocks. Here's what the data says about October performance.
Meta Platforms is not doing well. The social-media giant, parent of Facebook, Instagram and WhatsApp, has been sending alarming signals for several months. It was ejected from the world's top 10 most valuable companies, and this year its market capitalization has fallen by nearly $545 billion.
Yahoo Finance Live's Seana Smith looks at several stocks trending in the after-hours trading session.
The bear market in software stocks has already lasted far longer than the typical decline, according to MoffettNathanson,
Inflation, interest rates, and recession – these are the bogeymen of investing, and they’ve been watching over our shoulders for the past several months. We all know the story by now, the rate of inflation is running at generational highs, the Federal Reserve is hiking rates in an attempt to push back against high prices, and that’s likely to tip the economy into recession. At a time like this, investors are showing a growing interest in finding strong defensive portfolio moves. It’s a mindset t
Shares of Annaly Capital Management (NYSE: NLY) were among the losers this week as rising mortgage rates threatened to squeeze the mortgage REIT, and one analyst expressed caution on the stock. The company also executed a reverse stock split at the beginning of the week. Since the rate hike, which came with hawkish commentary from Fed Chair Jerome Powell, investors seem to believe the risk of a recession has grown, as well as the likelihood of a sustained high-interest-rate environment.
Carly is staying on top of the story and reports that there is “no immediate fix.” Eyeing that sweet capital: Manish has a scoop that Uniswap Labs, a decentralized exchange, is going after over $100 million in new funding. Stream on: YouTube TV is offering a new à la carte option that enables subscribers to purchase stand-alone networks without subscribing to the full channel lineup in its Base plan, Lauren reports.
Semiconductor stocks have tumbled in recent months amid flagging demand, with the S&P Semiconductors Select Industry Index dropping 36% year to date. Bank of America analysts recently discussed their favorite choices in the sector.
These two energy stocks largely avoid the ups and downs of oil prices, while this other one is tied directly to those gyrations.
New research based on the life-cycle model says that people should strive for a consistent standard of living through their lives.
Warren Buffet's mentor Benjamin Graham is famous for insisting that investors look at large declines in the stock market as a discount or sale, rather than panic. Here's a look at two quality tech stocks that have a chance to go back to their previous highs once macroeconomic conditions stabilize.
Two marathon runners tell BBC Newsbeat about overcoming the odds to compete in the London Marathon.
The stock market desperately wants to put in a low. The Federal Reserve won’t let it. On the one hand, U.S. economic data remains strong, as jobless claims fell below 200,000 for the first time since May, a sign that the Fed will have to keep raising interest rates to slow down inflation.
Portfolio Wealth Advisors President and CIO Lee Munson and Sound Planning Group CEO David Stryzewski join Yahoo Finance Live to discuss the recent market volatility, inflation, rising rates, and more.
Shares of gene therapy company Bluebird Bio (NASDAQ: BLUE) were up by a healthy 12.4% on heavy volume as of 11:16 a.m. ET Friday morning. The biotech's stock appears to be getting a boost from both a broad upward trend across the biotechnology space today, as well as from rumors circulating on social media about a possible buyout. Bluebird scored two approvals from the Food and Drug Administration (FDA) earlier this year for its one-and-done gene therapies: Skysona for cerebral adrenoleukodystrophy (CALD) and Zynteglo for transfusion-dependent beta-thalassemia (TDT).
The Dow Jones is at bear market lows. Tesla showed off the Optimus robot at AI Day. Tesla deliveries are on tap, with China EV rival Li Auto topping forecasts.